InnoCan Pharma's market cap is currently $55.24M. The company's EPS TTM is C$-0.182; its P/E ratio is ―; InnoCan Pharma is scheduled to report earnings on August 27, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
